STRATA Skin Sciences Inc Asset Resilience Ratio
STRATA Skin Sciences Inc asset resilience ratio. STRATA Skin Sciences Inc (SSKN) has an Asset Resilience Ratio of 0.00% as of June 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See STRATA Skin Sciences Inc liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of STRATA Skin Sciences Inc (2004–2017)
Asset resilience ratio of STRATA Skin Sciences Inc from 2004 to 2017. This chart shows how STRATA Skin Sciences Inc's Asset Resilience Ratio has changed over time. Read STRATA Skin Sciences Inc (SSKN) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down STRATA Skin Sciences Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see STRATA Skin Sciences Inc balance sheet assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: STRATA Skin Sciences Inc maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
STRATA Skin Sciences Inc Industry Peers by Asset Resilience Ratio
Compare STRATA Skin Sciences Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
STRATA Skin Sciences Inc Asset Resilience Ratio by Year (2004–2017)
STRATA Skin Sciences Inc asset resilience ratio by year from 2004 to 2017. The table below shows the annual Asset Resilience Ratio data for STRATA Skin Sciences Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2017-12-31 | 0.00% | $0.00 | $38.63 Million | -- |
| 2016-12-31 | 0.00% | $0.00 | $43.19 Million | -- |
| 2015-12-31 | 0.03% | $15.00K | $51.37 Million | -- |
| 2014-12-31 | 0.00% | $0.00 | $20.07 Million | -- |
| 2013-12-31 | 0.00% | $0.00 | $14.13 Million | -- |
| 2012-12-31 | 0.00% | $0.00 | $17.27 Million | -- |
| 2011-12-31 | 0.00% | $0.00 | $31.39 Million | -- |
| 2008-12-31 | 2.35% | $390.51K | $16.62 Million | -5.43pp |
| 2007-12-31 | 7.78% | $1.72 Million | $22.11 Million | -85.15pp |
| 2004-12-31 | 92.93% | $6.59 Million | $7.10 Million | -- |
About STRATA Skin Sciences Inc
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It operates through Dermatology Recurring Procedures and Dermatology Procedures Equipment segments. The company offers XTRAC excimer … Read more